SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 10, 2026

AXSM

Axsome Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago
Insider cluster: 3 insiders, $20.1M total
Actionable Insight • Neutral

The CEO and CFO selling simultaneously after option exercises is a routine cashless exercise pattern, not a bearish signal. Monitor next 10-Q for any fundamental deterioration, but this cluster alone does not warrant action.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$253.77
T+0 close · Jun 10, 2026 · via day close
Latest settled
−18.56%
T+60 · $206.68
Vs SPY
−22.95%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $253.77entry
  2. T+1 · 5mo ago +0.55%α +0.01% · $255.17
  3. T+5 · 5mo ago −0.63%α −1.07% · $252.16
  4. T+20 · 4mo ago −1.90%α −3.79% · $248.95
  5. T+60 · 2mo ago −18.56%α −22.95% · $206.68
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Herriot Tabuteau and CFO Nick Pizzie sold a combined ~$19.9M in open-market sales on June 9, 2026, following derivative exercises. Director Mark Coleman also sold $160K. The total open-market sales of ~$20.05M represent ~0.16% of AXSM's $12.6B market cap, a modest but notable cluster. The CEO and CFO selling simultaneously after exercising options is a common liquidity-driven pattern (cashless exercise-to-sell), not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$20.1M
Insiders
3

Key Facts

  • CEO Herriot Tabuteau sold 49,670 shares at $241.01 for ~$11.97M on June 9, 2026
  • CFO Nick Pizzie sold 33,000 shares at $240.09 for ~$7.92M on June 9, 2026
  • Both CEO and CFO exercised derivatives immediately prior to sales (cashless exercise-to-sell pattern)
  • Director Mark Coleman sold 643 shares at $249 for $160K on June 10, 2026
  • Total open-market sales: ~$20.05M, representing ~0.16% of AXSM's $12.6B market cap
  • No open-market purchases in the cluster; all non-cash transactions (grants, awards, derivative exercises) have $0 economic value

Financial Impact

Total open-market sales of ~$20.05M, ~0.16% of market cap, modest relative to company size

dilutioninsider ownership

Risk Factors

  • Insider sales could signal management's view of near-term headwinds, though the cashless exercise pattern mitigates this
  • Further insider selling in coming weeks would increase bearish weight
  • Stock is near all-time highs (~$246), profit-taking by insiders is natural

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-AXSM-1781142574601

Track record

26 reports on AXSM

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 2, 202614d ago 8-K Bullish 6/10 No price data
  2. Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
  3. Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
  4. Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
  5. Aug 10, 202614w ago 8-K Neutral 6/10 No price data
  6. Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
  7. Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
  8. Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
  9. Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
  10. Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 7h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026